It has been proposed that the antimitogenic action of progesterone (P 4 ) is mediated through a membrane receptor that has GABA A receptor-like characteristics. To test this hypothesis, studies were designed to compare the antimitogenic effects of P 4 with its gamma amino butyric acid A (GABA A ) receptor-activating metabolite, 5␣-pregnane-3␣-21-diol-20-one (5␣3␣). These studies revealed that P 4 was more effective than 5␣3␣ in blocking mitogen-dependent mitosis of both small granulosa cells ( ] i but also attenuated P 4 's antimitogenic effect. P 4 's actions appeared to be initiated at the membrane, since horseradish peroxidase conjugated-P 4 (HP-P 4 ), which is cell impermeable, was as effective in blocking mitosis as P 4 . Progesterone receptor (PR) mRNA was not detected in SIGCs by RT-PCR analysis, which is consistent with the findings in GCs. However, a 60-kDa protein was detected within crude membrane fractions of both GCs and SIGCs using an antibody directed against the ligand binding domain of the PR (C-262). This antibody was also used in immunocytochemical studies to detect a protein that was associated with the plasma membrane of SIGCs. It is proposed that this 60-kDa protein mediates P 4 's membrane-initiated actions.
INTRODUCTION
Progesterone (P 4 ) is a major steroid that is synthesized and secreted by the ovary [1, 2] . Although luteal cells have the greatest capacity to synthesize and secrete this steroid, granulosa cells (GCs) of preantral follicles also synthesize P 4 [3, 4] . In addition, the ability of GCs to synthesize P 4 increases throughout the course of follicular development [3, 4] . As a result, P 4 concentrations in preovulatory rat follicles can reach micromolar levels prior to the ovulatory gonadotropin surge [3] .
Work from several laboratories suggests that P 4 can directly influence GC function. It is clear that P 4 is involved in the ovulatory process, and this action appears to be mediated through the nuclear P 4 receptor (PR), which is induced by the ovulatory gonadotropin surge [2] . The expression of the PR is transient such that PR is only detected from 4 to 6 h after the gonadotropin surge [5] [6] [7] [8] . However, P 4 can modulate the function of GCs isolated prior to the gonadotropin surge. For example, in GCs isolated from immature rats, P 4 can inhibit FSH-induced estrogen secretion [9] and mitogen-dependent mitosis [10, 11] . Although these GCs do not express the PR [5, 6] , P 4 's ability to suppress GC mitosis is steroid-specific, dose-dependent, and reversed by 100-fold molar excess of RU 486 [10] [11] [12] .
Ligand binding studies, conducted in the late 1970s, demonstrate that GCs of immature rats specifically bind radiolabeled progestins [13] [14] [15] . More recent studies using spontaneously immortalized granulosa cells (SIGCs) reveal that these cells express a single high-capacity, low-affinity binding site for P 4 [16] . This binding site could function as a membrane receptor for P 4 . Support for this concept comes from several different experimental lines of evidence. First, FITC-BSA-conjugated P 4 binds to the plasma membrane in a steroid-specific manner [17] . Second, Western blot analysis using an antibody directed against the ligand binding domain of the PR (C-262) detects a 60-kDa protein that is present in the plasma membrane of both GCs and SIGCs [16] . Third, this 60-kDa protein binds P 4 [16] . Fourth, both FITC-BSA-conjugated P 4 binding and P 4 's antimitotic action are inhibited by C-262 [12, 17] . Collectively, these observations are consistent with the concept that this 60-kDa protein functions as a plasma membrane receptor for P 4 .
Several studies have shown that P 4 's action in both GCs [12] and sperm [18, 19] is influenced by the GABA A receptor antagonist, bicuculline. Given the GABA A receptor pharmacology and the fact that P 4 can modulate GABA A receptor activity [20, 21] , it is possible that P 4 's actions are mediated through a GABA A -like receptor. Interestingly, P 4 's metabolite, 5␣-pregnane-3␣-21-diol-20-one (5␣3␣) is more effective in activating the GABA A receptor than P 4 [20] , whereas 5␣-pregnane-3␤-21-diol-20-one (5␣3␤) does not effect the GABA A receptor activity [22] . Thus the first series of studies compared the antimitotic effects of 5␣3␣ and 5␣3␤ to that of P 4 . Subsequent studies focused on the mechanism through which P 4 mediates its antimitotic action.
MATERIALS AND METHODS

Animals and Reagents
Immature female Wistar rats (22 days of age) were obtained from Charles River Laboratory (Wilmington, MA) and housed under controlled FIG. 1. The effect of P 4 , 5␣3␣, and 5␣3␤ on insulin-dependent GC mitosis. In this and subsequent graphs, the data is expressed as a mean fold increase Ϯ 1 SEM. SEMs are not shown for the different steroid concentrations to improve graphic clarity. The lowest concentration that significantly suppressed mitosis is 40 nM for P 4 and 80 nM for 5␣3␣. An * indicates a value that is different from the control group (P Ͻ 0.05).
conditions of temperature, humidity, and photoperiod (12L:12D; lights-on at 0700 h). On the day of the experiment, immature animals were 23 or 24 days of age. The rats were killed by cervical dislocation between 0930 and 1000 h and the ovaries were removed. This protocol was approved by the Animal Care Committee of the University of Connecticut Health Center.
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO) unless otherwise stated. Insulin, progesterone (P 4 ), 5␣-pregnane-3␣-21-diol-20-one (5␣3␣), 5␣-pregnane-3␤-21-diol-20-one (5␣3␤), horseradish peroxidase-conjugated P 4 (HP-P 4 ), and bicuculline were added to cultures at various concentrations depending on the experimental design. The monoclonal antibody to the ligand binding domain of the PR (C-262) was purchased from StressGen (Victoria, BC, Canada). The PR cDNA was provided by Dr. O.K. Park-Sarge (University of Kentucky, Lexington, KY). The basic fibroblast growth factor (bFGF) was purchased from R&D Labs (Minneapolis, MN).
Granulosa Cell Isolation and Culture
Since small but not large GCs undergo insulin-dependent mitosis in vitro [23] , only small GCs were used in these studies. This population of GCs was isolated according to the procedure of Lederer et al. [23] . The small GCs were collected from fractions 3 and 4, washed and then suspended in RPMI-1640. Small GCs were plated at a density of 1.5-2 ϫ 10 5 cells/ml of RPMI-1640 and incubated at 37ЊC in 5% CO 2 in air with RPMI-1640 supplemented with the mitogen, insulin (5 g/ml), and other reagents as indicated. After 2 h, the media were replaced to remove any nonattached GCs. The number of remaining GCs was counted within 8 different 160-m 2 grids within the 35-mm dish [11] . The grids were located at the ends of horizontal and vertical axes and at the center of each dish. After 24 h of culture, the number of GCs present in these same areas was determined. Cell proliferation was expressed as a fold increase in cell number over 2 h control values.
Spontaneously Immortalized Granulosa Cell (SIGC) Culture
SIGCs were generously provided by Dr. Robert Burghardt of Texas A&M University (College Station, TX) and cultured as previously described [24] . For binding studies, cells were plated in 35-mm culture dishes. For the SIGC mitosis studies, the cells were plated at 1.25 ϫ 10 4 cell/ ml on plastic culture dishes in 2 ml of serum-containing medium that was supplemented with the vehicle (control), P 4 , 5␣3␣, or 5␣3␤. After 6 h the number of cells within 4 grids were counted. The number of cells in these grids was counted again after 24 and/or 48 h of culture depending on the experimental design. The fold increase in cell number was then calculated as previously described.
In the studies involving mitosis and supplemental calcium, 1 ϫ 10 6 cells were plated on 60-mm glass Petri dishes for 24 h in serum-containing medium. Then the medium with a 1 mM concentration of CaCl 2 was supplemented with the vehicle (ethanol), P 4 , and/or CaCl 2 such that the final concentrations were 1 M and 1.5 mM for P 4 and CaCl 2 , respectively. At 6 and 24 h, the cells were counted in a hematocytometer. The increase in cell number compared to the 6 h control was then calculated.
Intracellular Free Calcium ([Ca 2ϩ ] i ) Measurements
For these studies, SIGCs were plated on glass coverslips in serumsupplemented medium for 6 h and then cultured for 18 h in serum-free medium supplemented with bFGF (6 ng/ml). The cells were then loaded with Fluo-4 (Molecular Probes, Eugene, OR) for 30 min [25] , rinsed in Kreb-Hepes buffer (pH 7.3) with 1 M P 4 , and the Fluo-4 fluorescence were assessed under 3 experimental conditions. After a 3.5-min stabilization period, either P 4 was removed, maintained, or CaCl 2 was added to P 4 -supplemented Kreb-Hepes buffer such that extracellular calcium levels increased by 50%. Next, [Ca 2ϩ ] i levels were determined at 30-sec intervals for 10 min of culture as previously described [25] . To determine the actual intracellular concentration of calcium, calcium ionophore, A23187 (50 M; Sigma) was added after 10 min to determine maximum fluorescent intensity (F max ). EGTA (7 mM; Sigma) was then added and the minimum fluorescent intensity determined (F min ). The [Ca 2ϩ ] i was estimated by the following equation: nM intracellular free calcium ϭ 345 nM (F Ϫ F min )/ (F max Ϫ F) [25] .
Western Blot and Immunocytochemical Analysis
Small GCs and SIGCs were lysed in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (20 mM MOPS, 5 mM sodium acetate, 0.7 mM EDTA, pH 7.0), which was supplemented with a complete protease inhibitor cocktail (Roche, Mannheim, Germany) and phosphatase inhibitor cocktail 1 (Sigma) and then centrifuged at 1000 ϫ g at 4ЊC for 5 min. The supernatant was collected and centrifuged at 100 000 ϫ g for 60 min at 4ЊC. The membrane pellets were stored at Ϫ20ЊC.
Levels of 60-kDa P 4 binding protein were assessed by using the antibody C-262 in a Western blot analysis. Briefly, 20 g of membrane preparation was run on a 10% acrylamide gel and transferred to nitrocellulose. The nitrocellulose was then incubated with 5% nonfat dry milk overnight at 4ЊC. The nitrocellulose blot was incubated with C-262 antibody at a dilution of 1:1000 (1.9 g/ml) for 1 h at room temperature and processed for Western blot analysis as previously described [16] .
Protein detected by C-262 was localized to the plasma membrane by staining living cells as outlined previously [26] . Briefly, cells were rinsed with PBS and then incubated in the presence of either a C-262 antibody (1:50 in 8% BSA/PBS) or IgG for 15 min at room temperature. After this incubation, the cells were washed in PBS and incubated with FITC-IgG (1:100 in 8% BSA/PBS) for 15 min in the dark at room temperature. The cells were then washed with PBS and observed under phase and standard epifluorescent optics.
Ligand Binding Studies
The protocol used to assess the total cellular binding of 3 H-P 4 to SIGCs has been previously described [16, 27] . Briefly, SIGCs were plated at 3.6 ϫ 10 5 cells/35-mm culture dish and cultured overnight in a serum-supplemented medium. The cells were washed twice in PBS and then incubated at 4ЊC in 500 l of 0.1% digitonin in a TEMGD buffer (10 mM TRISHCl, pH 7.4, 1.5 mM EDTA, 10% glycerol, 25 mM sodium molybdate, and 1 mM dithiothreitol). After 30 min, 1,2,6,7-3 H-progesterone (1 nM 3 H-P 4 , 50 000 cpm, SA ϭ 86 Ci/mmol; Amersham, Arlington Heights, IL) was added and the incubation continued for an additional 60 min. The cells were then washed several times, harvested and filtered through Whatman Glass Microfiber filters (GF/F; Fisher Scientific Inc., Pittsburgh, PA), rinsed twice with 1 ml cold PBS, and the filters were counted in a scintillation counter. Displacement studies were conducted in which the effect of increasing concentrations of nonlabeled P 4 , 5␣3␣, and 5␣3␤ on 3 H-P 4 binding was determined. For each experiment, each concentration was tested in duplicate with the entire experiment repeated at least 3 times. The dissociation constant (K d ) for each steroid was calculated using the Ligand program provided by the National Institutes of Health. Reverse Transcriptase-Polymerase Chain Reaction Detection of the PR and Alpha Chains of the GABA A Receptor RNA from SIGCs was isolated using the RNAzol isolation system following the manufacturer's instructions (Biotecx, Houston, TX). For reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, 2 g of total RNA was converted to first-strand cDNA with SuperScript II RNaseH Ϫ reverse transcriptase and oligo-dT primer (Life Technologies, Gaithersburg, MD). PCR was performed using 20% of the RT reaction product as template with primers specific for the ligand binding domain of the nuclear PR. The sense primer was identical to that described by Park and Mayo [28] (5Ј-GATGACCAGATAACTCTCAT-3Ј) and the antisense primer (5Ј-GTGAAAGAGAGAGGCTTC-3Ј) ends at position 2763 (accession L16922; [6] ). The alpha chains of the GABA A receptor were detected using the primer pairs and protocol of Liu and Burt [29] .
The RT-PCR protocol to assess the expression of the PR in SIGCs was conducted as follows. In addition to SIGC cDNA, the PCR reaction also contained 1X PCR buffer (Life Technologies), 1.5 mM MgCl 2 , 1 pmol/l of each primer, 200 M of each deoxynucleotide (dATP, dCTP, dGTP, and dTTP; Promega, Madison, WI), and 2.5 U of recombinant Taq polymerase (Life Technologies). Amplification of primer products by 30 cycles of PCR in a thermal cycler followed this profile: 94ЊC denaturation, 1 min; 72ЊC primer hybridization, 1 min; 72ЊC extension, 1 min; 72ЊC final extension, 10 min. Forty-five nanograms of PR cDNA, which was provided by Dr. O.K. Park-Sarge (University of Kentucky), was also included as a positive control. An aliquot of each PCR reaction was separated on a 1.5% agarose gel containing ethidium bromide (0.5 g/ml) and visualized under UV light.
The RT-PCR reaction to detect moesin was also run as a positive control. Rat moesin primers were designed from positions 1831 to 2075 (accession AF004811; sense: 5Ј-AGTGGGCGCGCAGCCGTTAGGGAC-3Ј; antisense: 5Ј-GCTATGTTGAATGAGTGTGACAAAG-3Ј).
Statistical Analysis
All experiments were repeated at least 2-3 times with each experiment yielding essentially identical results. When appropriate, the data were pooled and analyzed by a one-way ANOVA followed by a Student-Newman-Keuls test. P values of less than 0.05 were considered to be significant.
RESULTS
P 4 suppressed insulin-dependent GC mitosis in a dosedependent manner (Fig. 1) . Although 5␣3␣ was effective, 5␣3␤ was ineffective in suppressing insulin-dependent GC mitosis. Compared to P 4 , higher doses of 5␣3␣ were required to attenuate the mitogenic effect of insulin.
The ability of P 4 to regulate SIGC mitosis was also evaluated. In these studies, 10% bovine fetal serum was used as a mitogen. In the presence of serum the number of SIGCs increased 2-to 3-fold by 48 h of culture ( Fig. 2A) . Similar to GC studies, serum-dependent growth was inhibited by P 4 (Fig. 2, A-C) and 5␣3␣ (Fig. 2C) , but higher doses of 5␣3␣ were required to inhibit mitosis. Serum-dependent mitosis was not inhibited by 5␣3␤ (Fig. 2C) .
3 H-P 4 binding studies were conducted on SIGCs in order to correlate mitotic effects of P 4 and its metabolites with their ability to displace 3 H-P 4 . Nonlabeled P 4 displaced 3 H- 4 and HP-P 4 on insulin-dependent GC mitosis (A) and serum-dependent SIGC mitosis (B). The P 4 concentration was 160 nM and 1 M for the experiments shown in A and B, respectively. Since there was approximately 1 molecule of P 4 conjugated to each molecule of horseradish peroxidase, HP-P 4 was used at the same molarity as P 4 . An * indicates a value that is different from the control group (P Ͻ 0.05). (Fig. 3) . 5␣3␤ was ineffective in displacing 3 H-P 4 binding at concentrations less than 10 Ϫ5 M (Fig. 3) . In GCs, a GABA A receptor antagonist, bicuculline, partially attenuates P 4 's antimitotic effects [12] . Bicuculline alone did not significantly alter serum-induced SIGC proliferation (P Ͼ 0.05; Fig. 4A ). In contrast, P 4 alone or in the presence of bicuculline reduced the fold increase in the number of cells compared to both the serum control group (P Ͻ 0.05) and bicuculline group (P Ͻ 0.05). Since bicuculline acts by binding to the alpha chain of the GABA A receptor [21] , the expression of the 6 known alpha chains was assessed in SIGCs by RT-PCR. Although each alpha chain was detected within RNA isolated from rat brain (i.e., a positive control), none of the alpha chains were detected in RNA isolated from SIGCs (Fig. 4B) .
To assess whether P 4 's antimitotic actions were initiated at the membrane, GCs and SIGCs were cultured with insulin or serum, respectively, in the presence of P 4 or a cellimpermeable P 4 conjugate (i.e., P 4 conjugated with horseradish peroxidase, HP-P 4 ). As shown in Figure 5, A (Fig. 6A) . Similarly, P 4 's ability to inhibit mitosis was abrogated by increasing extracellular calcium by 50% (Fig. 6B) .
Although previous studies have shown that the PR is not expressed in primary GCs [5, 6] , PR expression has not been assessed in SIGCs. Using RT-PCR, RNA that encodes the PR was not detected within SIGC preparations, although a specific and appropriate-sized RT-PCR product was detected in the presence of PR cDNA (Fig. 7A ). Moesin was readily detectable by RT-PCR in these SIGC RNA extracts (Fig. 7A) .
As seen in Figure 7B , the PR antibody (C-262) detects a 60-kDa protein within crude membrane preparations of GCs and SIGCs. Further, C-262 specifically bound to the surface membrane of living SIGCs (Fig. 8) .
DISCUSSION
Several studies have shown that P 4 can directly influence the mitogenic [10, 12, 17] and steroidogenic [9, 30] activity of GCs isolated from immature rats. Because these cells do not express the PR [5, 6] , the mechanism through which P 4 mediates its actions in these GCs remains to be defined. One of the limiting factors in elucidating P 4 's antimitotic mechanism is that large numbers of GCs are required to conduct these studies. The present studies resolve this limitation by demonstrating that P 4 inhibits the proliferation of spontaneously immortalized cells that were derived from primary GCs (i.e., SIGCs) [24] . Therefore, studies can now be conducted on both primary GCs and SIGCs to more fully elucidate the antimitotic action of P 4 .
It has been suggested that P 4 's antimitotic mechanism involves a GABA A -like receptor [12] . The rat ovary has high levels of GABA [31] [32] [33] , and primary GCs express GABA A receptors [33, 34] . Therefore it is likely that these cells possess a basal GABA A receptor activity level that is maintained by endogenous levels of both P 4 , which can activate the GABA A receptor [20] , and GABA. This en- dogenous basal GABA A receptor activity may suppress GC mitosis, since the GABA A receptor antagonist, bicuculline, attenuates in part P 4 's antimitotic action in GCs [12] .
Although P 4 -GABA A receptor interaction may have a role in regulating GC mitosis, it does not appear to be the dominant mechanism through which P 4 inhibits proliferation. This conclusion is based on the following observations. First, if a GABA A -like receptor mediates P 4 's actions, then the anesthetic, GABA A -activating metabolite of P 4 , 5␣3␣, would be more effective than P 4 in inhibiting GC mitosis, since 5␣3␣ is 12 times more potent than P 4 in activating GABA A receptors [20] . Conversely, 5␣3␤, a nonanesthetic, non-GABA A -activating isomer of 5␣3␣ [22] , would not inhibit GC mitosis. Although 5␣3␣ inhibits and 5␣3␤ does not effect GC and SIGCs mitosis, 5␣3␣ is less effective than P 4 . This reduced ability of 5␣3␣ and 5␣3␤ to prevent GC and SIGC proliferation correlates with their reduced capacity to displace 3 H-P 4 binding to SIGCs. This could indicate that both P 4 and 5␣3␣ bind to the same receptor to inhibit mitosis (see subsequent discussion). Second, bicuculline does not attenuate P 4 's antimitotic action in SIGCs. Bicuculline interferes with GABA A receptor function by interacting with the alpha chain of the GABA A receptor [21] . Since none of the known alpha chains of the GABA A receptor are expressed by SIGCs, this accounts for the inability of bicuculline to effect SIGC mitosis. Finally, P 4 inhibits both GCs and SIGCs within the same dose response range even though the bicuculline-sensitive antimitotic mechanism is not present in SIGCs. Taken together, these observations suggest the existence of a non-GABA A receptor mechanism through which P 4 prevents GC and SIGC mitosis.
This non-GABA A receptor pathway may be mediated by a membrane receptor for P 4 . Three lines of evidence support this concept. First, FITC-BSA-P 4 specifically binds to the surface membranes of GCs [17] . Second, the cell-impermeable P 4 , HP-P 4 , inhibits mitosis at the same concentrations as P 4 . Third, P 4 induces a 15%-20% decrease in [Ca 2ϩ ] i levels within seconds [16] . Although this rapid change in [Ca 2ϩ ] i is consistent with a membrane-initiated event, it is conceivable that an intracellular site of action is also responsible for changes in [Ca 2ϩ ] i .
The ability of P 4 to suppress basal [Ca 2ϩ ] i appears to be related to its antimitotic effect. In normal healthy porcine [35] , human [36] , and rat GCs [37] as well as SIGCs [25] that occur at specific stages of the cell cycle [39] [40] [41] . These increases in [Ca 2ϩ ] i are sufficient to allow the transition from G 0 /G 1 to the S phase of the cell cycle [39] . If these calcium transits are buffered by the intracellular calcium chelator, 1,2-bis(2-aminophenoxy)ethane-N, N, NЈ, NЈ-tetraacetic acid (BAPTA), then the cells do not traverse the cell cycle [40] . Based on the essential role of calcium transits in stimulating the cell cycle, P 4 could prevent the cell-cycle-dependent calcium transits from occurring, and thereby prevent GC mitosis. Alternatively, mitogens could induce cell-cycle-dependent calcium transits, but since the basal [Ca 2ϩ ] i levels would be lower in P 4 -treated cells, the calcium transits may not be able to increase [Ca 2ϩ ] i to the level required to induce the subsequent cell-cycle events.
The molecular mechanism by which [Ca 2ϩ ] i levels regulate early events of the cell cycle is just beginning to be understood. In GCs, insulin induces the expression of 2 immediate/early genes, c-fos and c-jun, which are required for GCs to undergo insulin-dependent mitosis [11] . Further, P 4 blocks the insulin-dependent expression of c-fos and cjun [11] . Recent studies have shown that a transient increase in [Ca 2ϩ ] i precedes the mitogen-dependent increase in c-fos and c-jun expression [42, 43] . If this increase in [Ca 2ϩ ] i is abrogated by BAPTA, then c-fos and c-jun levels are not increased [42] . Similarly, tumor cells, which overexpress c-fos and c-jun, have higher levels of [Ca 2ϩ ] i than do the nontransformed cells [43] . Lowering [Ca 2ϩ ] i by BAPTA treatment also reduces c-fos and c-jun levels [43] . Since in other cells increases in [Ca 2ϩ ] i play an important role in inducing c-fos and c-jun expression, the ability of P 4 to suppress [Ca 2ϩ ] i could account for its ability to inhibit insulin-dependent expression of c-fos and c-jun and subsequently GC mitosis.
Although it is likely that increased extracellular calcium attenuates P 4 antimitotic action by increasing [Ca 2ϩ ] i , it is also possible that increases in extracellular calcium promote mitosis independently of its actions on [Ca 2ϩ ] i levels. In ovarian surface epithelial cells, increasing the extracellular calcium concentration from 0.8 mM to either 1.4 or 1.8 mM induces a 2-fold increase in 3 H-thymidine incorporation within 16 h [44] . A similar fold increase in cell number is observed by 48 h after increasing extracellular calcium [44] . The increase in cell proliferation in ovarian surface epithelial cells appears to be mediated through a calciumsensing receptor, which has been shown to activate the mitogen-activated protein (MAP) kinase cascade [44, 45] . In the present studies, extracellular calcium was increased from 1 to 1.5 mM. However, SIGCs cultured with serum and calcium supplementation do not proliferate at a greater rate than those cells cultured with serum alone. Since serum could mask any mitogenic action of extracellular calcium, SIGCs were cultured with bFGF, which maintains cell viability without promoting mitosis [46] . In the presence of bFGF, increasing extracellular calcium was not mitogenic (1.37 Ϯ 0.08-fold increase in cell number for bFGF verses 1.23 Ϯ 0.07-fold increase in cell number for bFGF plus supplemental CaCl 2 ; n ϭ 6, P Ͼ 0.05; unpublished results). Although the present studies do not support the concept that increasing extracellular calcium promotes mitosis by activating calcium-sensing receptors, detailed molecular studies are required to completely rule out this possibility.
The present study also demonstrates that the cell-impermeable P 4 conjugate, HP-P 4 , prevents mitogen-dependent mitosis in both GCs and SIGCs. This implies that P 4 inhibits mitosis by regulating membrane-initiated events. A membrane-initiated mechanism accounts for P 4 's actions in both sperm [47, 48] and oocytes [49] . Recent studies have shown that PR mRNA can be detected in these gametes [50] [51] [52] . Further, small amounts of the PR can localize to the plasma membrane of oocytes and function as membrane receptors for P 4 [51, 52] . Moreover, PR interacts with SH3 domains and activates Src family tyrosine kinases and has also been associated with P42 MAP kinase and phosphatidylinositol 3-kinase, thereby linking PR to signal transduction pathways that are initiated at the plasma membrane [53, 54] . Collectively, these studies indicate that the PR can localize to the plasma membrane and function as a P 4 membrane receptor. The localization of the PR to the membranes of GCs and SIGCs, however, does not provide a mechanism that explains P 4 's ability to regulate GC function. This conclusion is based on the failure of RT-PCR protocols to detect PR in both primary GCs [6] and SIGCs (present study). As previously demonstrated, an antibody to the ligand binding domain of the PR (i.e., C-262) has detected a 60-kDa protein within crude membrane preparations of GCs and SIGCs [16] . Immunocytochemical studies using C-262 detect this protein at the surface membrane of SIGCs. Finally, blocking antibody studies have demonstrated that C-262 abrogates the binding of FITC-BSA-conjugated P 4 to GCs [17] as well as P 4 's antimitotic effects [12] . Taken together, these data seem to indicate that this 60-kDa protein, which is detected by C-262, is as a novel membrane receptor for P 4 . The identity of the putative membrane receptor is presently under investigation.
